These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15472191)

  • 1. Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women.
    Rapuri PB; Gallagher JC; Haynatzki G
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4954-62. PubMed ID: 15472191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
    Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women.
    Huang AJ; Ettinger B; Vittinghoff E; Ensrud KE; Johnson KC; Cummings SR
    J Bone Miner Res; 2007 Nov; 22(11):1791-7. PubMed ID: 17620054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.
    Khosla S; Melton LJ; Atkinson EJ; O'Fallon WM
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3555-61. PubMed ID: 11502778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
    van den Beld AW; de Jong FH; Grobbee DE; Pols HA; Lamberts SW
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3276-82. PubMed ID: 10999822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study.
    Goderie-Plomp HW; van der Klift M; de Ronde W; Hofman A; de Jong FH; Pols HA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3261-9. PubMed ID: 15240601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
    JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study.
    Szulc P; Munoz F; Claustrat B; Garnero P; Marchand F; Duboeuf F; Delmas PD
    J Clin Endocrinol Metab; 2001 Jan; 86(1):192-9. PubMed ID: 11232000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
    Van Pottelbergh I; Goemaere S; Kaufman JM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.
    Martínez Díaz-Guerra G; Hawkins F; Rapado A; Ruiz Díaz MA; Díaz-Curiel M
    Osteoporos Int; 2001; 12(3):178-84. PubMed ID: 11315235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in men: a potential role for the sex hormone binding globulin.
    Legrand E; Hedde C; Gallois Y; Degasne I; Boux de Casson F; Mathieu E; Baslé MF; Chappard D; Audran M
    Bone; 2001 Jul; 29(1):90-5. PubMed ID: 11472897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.
    Gennari L; Merlotti D; Martini G; Gonnelli S; Franci B; Campagna S; Lucani B; Dal Canto N; Valenti R; Gennari C; Nuti R
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5327-33. PubMed ID: 14602769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial.
    Greenspan SL; Resnick NM; Parker RA
    J Clin Endocrinol Metab; 2005 May; 90(5):2762-7. PubMed ID: 15713726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture.
    Evans SF; Davie MW
    Calcif Tissue Int; 2002 Jan; 70(1):9-15. PubMed ID: 11907702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
    Legroux-Gerot I; Vignau J; Collier F; Cortet B
    Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S; Boermans AJ
    Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.